
ShareLab
AI Verified
Norway
Accelerator/Incubator
21 Gaustadalléen, 0349 Oslo, Norway
2018
Criteria | Requirements | Match |
---|---|---|
Regions | North America, Northern Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Pre-Seed, Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
ShareLab stands as the leading incubator in Scandinavia dedicated to supporting ambitious bioentrepreneurs in their journey to success. Strategically positioned within Oslo Science Park, this innovative hub provides a collaborative environment where scientific talent meets entrepreneurial vision. The organization has established itself as a cornerstone of the Nordic biotech ecosystem, offering specialized laboratory facilities, mentorship programs, and strategic resources tailored specifically for early-stage biotech ventures. ShareLab's mission centers on transforming promising scientific discoveries into commercially viable healthcare solutions.
The incubator offers a comprehensive support system that includes access to state-of-the-art laboratory equipment, reducing the capital expenditure burden typically faced by biotech startups. This shared infrastructure model allows founding teams to allocate resources more efficiently toward research and development activities. Beyond physical resources, ShareLab provides expert guidance through its network of industry veterans, scientific advisors, and investment professionals who understand the unique challenges of biotech commercialization. Their hands-on approach to mentorship has significantly improved the success rate of portfolio companies navigating the complex path from research to market.
With a focus on therapeutic innovations, diagnostic technologies, and life science tools, ShareLab has cultivated a diverse portfolio of promising ventures addressing critical healthcare challenges. The incubator demonstrates particular strength in supporting companies working in areas such as precision medicine, immunotherapies, and sustainable biotechnology solutions. Their selection process emphasizes scientific rigor, market potential, and founding team capabilities, resulting in a high-caliber community of bioentrepreneurs. This selective approach has enabled ShareLab to develop a reputation for quality that attracts follow-on investment from both Nordic and international venture capital firms.
ShareLab's strategic vision extends beyond individual company success to the broader goal of establishing Scandinavia as a globally recognized biotech innovation hub. By fostering cross-border collaboration between Denmark, Norway, Sweden, and Finland, the incubator leverages the region's combined strengths in life sciences research, healthcare systems, and technological expertise. Their ecosystem-building initiatives include regular knowledge-sharing events, investor showcases, and partnerships with academic institutions. This holistic approach to biotech development has positioned ShareLab as an essential catalyst in transforming Scandinavia's rich scientific heritage into commercial success stories with global impact.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
ShareLab maintains its global headquarters in Norway, serving as the strategic center for its operations. The company's primary corporate offices are located at 21 Gaustadalléen, 0349 Oslo, Norway.
ShareLab focuses its investment activities on companies operating in the following stages: Pre-Seed, Seed. ShareLab provides strategic capital and expertise to support promising businesses at these critical phases of development.
ShareLab maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Northern Europe.
ShareLab was established in 2018, marking the beginning of its journey as an investment firm.
ShareLab is the following type of investment firm: Accelerator/Incubator. The organization provides capital and strategic support to entrepreneurs and growing companies.